JESSICA CARTER: Open Payments
NPI 1508256702 · OREGON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 20 payments from 9 companies in 2025. Trend: 2023 $661 · 2024 $1,098 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 8 | $145 |
| MIMEDX Group, Inc. | 4 | $127 |
| Smith+Nephew, Inc. | 2 | $35 |
| Organogenesis Inc. | 1 | $29 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Boston Scientific Corporation | 1 | $21 |
| HARTMANN USA, INC. | 1 | $17 |
| Integra LifeSciences Corporation | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: Kerecis SurgiClose, APLIGRAF, NUZYRA, GRAFIX PL, ROTAPRO, ColActive Plus 2x2, TCC-EZ, Ozempic.
Industry payments across OH — which companies pay providers there.
